Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Infection control during GI endoscopy.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Definitions for the grades of recommendation (1A to 3) are provided at the end of the "Major Recommendations."

Reprocessing of Endoscopes

Definitions

Cleaning: This is defined as the physical removal of organic material and/or soil, usually by using water with detergents. This process is designed to remove microorganisms rather than to kill them.

Disinfection: Disinfection accomplishes the killing of most microorganisms and is commonly performed by using liquid chemical germicides (LCG). Three levels of disinfection are achievable: high, intermediate, and low, depending on the amount and kind of microbial killing involved. High level disinfection (HLD) destroys vegetative microorganisms, mycobacteria, fungi, small or nonlipid viruses, medium or lipid viruses, but not necessarily large numbers of bacterial spores. Chemical germicides registered as "sterilants" may be used for sterilization or for HLD, depending on such factors as dilution, contact time, and frequency of reuse. The specifics of such factors may vary with each product and are included on approved labeling.

Sterilization: Sterilization is the act of killing all microbial life, including the elimination of bacterial spores. It is most commonly achieved with heat or ethylene oxide gas. The Spaulding classification system allows categorization of medical devices based on the risk of infection involved with use. The categories of medical devices and their associated level of disinfection are as follows:

  • Critical use items: Items that enter sterile tissue or vascular spaces and hence carry significant risk for infection if contaminated. These items include needles, surgical instruments, biopsy forceps, and urinary catheters. Processing for reuse of these items requires sterilization. In some instances, gastrointestinal (GI) endoscopes are sterilized when intended for use in sterile environments.
  • Semicritical use items: Items that come in contact with mucous membranes and do not ordinarily penetrate sterile tissue. These include thermometers, endoscopes, and anesthesia equipment. Processing for reuse of these items requires at least HLD.
  • Noncritical items: Items that do not ordinarily touch the patient or touch only intact skin, such as stethoscopes or patient carts. These items may be cleaned by low-level disinfection.

Summary

  • Transmission of infection as a result of GI endoscopes is extremely rare, and recently reported cases are invariably attributable to lapses in currently accepted endoscope reprocessing protocols or to defective equipment. (Level 1C+)
  • Endoscopes should undergo HLD as recommended by governmental agencies and all pertinent professional organizations for the reprocessing of GI endoscopes. (Level 1C+)
  • Extensive training of staff involved in endoscopic reprocessing is mandatory for quality assurance and for effective infection control. (Level 1C)
  • General infection control principles should be adhered to at the endoscopy unit. (Level 1C+)
  • Transmission of infection from patients to endoscopy personnel can be avoided by application of standard precautions. (Level 1C+)

Definitions:

Grade of Recommendation Clarity of Benefit Methodologic Strength Supporting Evidence Implications
1A Clear Randomized trials without important limitations Strong recommendation; can be applied to most clinical settings
1B Clear Randomized trials with important limitations (inconsistent results, nonfatal methodologic flaws) Strong recommendation; likely to apply to most practice settings
1C+ Clear Overwhelming evidence from observational studies Strong recommendation; can apply to most practice settings in most situations
1C Clear Observational studies Intermediate-strength recommendation; may change when stronger evidence is available
2A Unclear Randomized trials without important limitations Intermediate-strength recommendation; best action may differ depending on circumstances or patients' or societal values
2B Unclear Randomized trials with important limitations (inconsistent results, nonfatal methodologic flaws) Weak recommendation; alternative approaches may be better under some circumstances
2C Unclear Observational studies Very weak recommendation; alternative approaches likely to be better under some circumstances
3 Unclear Expert opinion only Weak recommendation; likely to change as data become available

*Adapted from Guyatt G, Sinclair J, Cook D, et al. Moving from evidence to action. Grading recommendations: a qualitative approach. In: Guyatt G, Rennie D, editors. Users' guides to the medical literature. Chicago: AMA Press; 2002. p. 599-608.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2008 May

GUIDELINE DEVELOPER(S)

American Society for Gastrointestinal Endoscopy - Medical Specialty Society

SOURCE(S) OF FUNDING

American Society for Gastrointestinal Endoscopy

GUIDELINE COMMITTEE

Standards of Practice Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee Members: Subhas Banerjee, MD; Bo Shen, MD; Douglas B. Nelson, MD; David R. Lichtenstein, MD; Todd H. Baron, MD, (Chair); Michelle A. Anderson, MD; Jason A. Dominitz, MD, MHS; S. Ian Gan, MD, FRCPC; M. Edwyn Harrison, MD; Steven O. Ikenberry, MD; Sanjay B. Jagannath, MD; Robert D. Fanelli, MD, SAGES Representative; Ken Lee, MD, NASPGHAN Representative; Trina van Guilder, RN, SGNA Representative; Leslie E. Stewart, RN, SGNA Representative

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Society for Gastrointestinal Endoscopy Web site.

Print copies: Available from the American Society for Gastrointestinal Endoscopy, 1520 Kensington Road, Suite 202, Oak Brook, IL 60523

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on September 15, 2008. The information was verified by the guideline developer on October 31, 2008.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo